Big Pharma Discharged by Chinese Doctors

Eagle Eye Opener

Big Pharma Discharged by Chinese Doctors (YahooFinance)

Doctors are now refusing to see pharmaceutical reps in China, for fear of being implicated in the growing drug scandal there. Big Pharma is taking a hit to be sure, with drug sales in China waning sharply. GlaxoSmithKline Plc is getting hardest hit with sales growth expected to drop sharply and perhaps even reverse for the third quarter of this year. And in a market where pharmaceutical sales are expected to hit $1 trillion by 2020, from $357 billion in 2011, any reversal in growth can be devastating for a company’s future intentions. Just as it can be a disaster for investors backing a company like Glaxo, if doctors’ fears of accepting visits from pharmaceutical representatives remain.

Exclusive  Would a Single-Payer Health Care System Save Money?

Like This Article?
Now Get Mark's FREE Special Report:
3 Dividend Plays with Sky-High Returns

This newly-released report by a top-20 living economist details three investments that are your best bets for income and appreciation for the rest of the year and beyond.

Get Access to the Report, 100% FREE


img
previous article

Today, analysts and investors alike fully expect the U.S. Federal Reserve to start what has long-been rumored: tapering the United States’ $85 billion a month stimulus plan.

PREMIUM SERVICES FOR INVESTORS

Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details

LEARN MORE HERE

Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details

LEARN MORE HERE

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details

LEARN MORE HERE

Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details

LEARN MORE HERE

Mike Turner

Mike Turner’s financial, mathematical, computer science and engineering background serves as the foundation for his disciplined, rules-based approach to trading. Mike’s three services include:

Product Details

LEARN MORE HERE

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details

LEARN MORE HERE

DividendInvestor.com

Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

LEARN MORE HERE